期刊文献+

自旋探针α-苯基-N-4-丁基硝酮纳米粒的制备及其对肝肿瘤细胞的亲和性研究 被引量:3

Preparation of the spin trapping probe,N-tert-butyl-α-phenylnitrone,nanoparticle and its affinity to hepatoma cells
下载PDF
导出
摘要 采用薄膜分散-超声法制备、优化自旋捕捉剂α-苯基-N-4-丁基硝酮(Nt-ert-butyl-α-phenyln itrone,PBN)脂质体,并研究其相关性质。以人肝肿瘤细胞SMMC-7721为实验对象,采用反相高效液相法(RP-HPLC)测定细胞内PBN的浓度,以此评价PBN脂质体对细胞的亲和性;考察了PBN脂质体对细胞生长的影响。结果显示,采用正交设计优化得到PBN脂质体的平均粒径137.5 nm,包封率71.52%,多分散系数0.286。PBN脂质体可稳定进入癌细胞内,同游离的PBN相比,PBN脂质体对肝肿瘤细胞更具亲和性,转染后癌细胞坏死率更高。表明自旋捕捉剂脂质体对肝肿瘤细胞具有较好的亲和性并能明显抑制其生长。为研究肿瘤自旋靶向性干预提供了实验依据。 This article describes the preparation of the N-tert-butyl-α-phenylnitrone (PBN) liposomes and their related characteristics. The PBN liposomes were prepared by film dispersion-supersonic method and the formula of liposomes was optimized by orthogonal uniform design. RP-HPLC was used to qualify the amount of PBN that entered into the hepatoma cells. Necrosis rate was also investigated by fluorescence activated cell sorter (FACS) after PBN liposomes transfection. Result showed that the mean particle size, entrapment efficiency, and polydispersity of the resulting PBN-liposome were 137.5 nm, 71.52% and 0. 286, respectively. PBN liposomes can enter into the tumor cell stably and they have higher affinity to hepatoma cell compared with free PBN resulting in a higher necrosis rate after transfection. These results provide a potential method for early diagnosis and treatment of cancer using specific spin trapping probe targeting tumor cells.
出处 《药学学报》 CAS CSCD 北大核心 2008年第3期308-313,共6页 Acta Pharmaceutica Sinica
基金 国家自然科学基金重点项目(30130100)
关键词 肝肿瘤细胞 自由基 脂质体 α-苯基-N-4-丁基硝酮 hepatoma cell free radical liposome N-tert-butyl-α-phenylnitrone
  • 相关文献

参考文献16

  • 1Shi DY, Deng YR, Liu SL, et al. Redox stress regulates cell proliferation and apoptosis of human hepatoma through AKT protein phosphorylation [J]. FEBS Letter, 2003,542:60 - 64.
  • 2Liu SL, Shi DY, Liu GZ, et al. Roles of Se and NO in apoptosis of hepatoma cells [ J ]. Life Sci, 2001 , 68- 603 - 610.
  • 3Rutauh K, Alderman C, Chain BM, et al. Reactive oxygen species activate human peripheral blood dendritic cells [J]. Free Radic Biol Med, 1999,26:232-238.
  • 4Wan DF, Gong Y, Qin WX, et al. Large-scale cDNA transfection screening for genes related to cancer development and progression [ J]. PNAS, 2004, 101 : 15724 - 15729.
  • 5Emily H, Gouman C, Tammy MB. Alpha-phenyl-tertbutyl nitrone (PBN) inhibits NFκB activation offering protection against chemically induced diabetes [ J]. Free Radic Biol Med, 2000,28:604 - 614.
  • 6Miyajima T, Kotake Y. Spin trapping agent, phenyl N- tert-butyl nitrone, inhibit induction of nitric oxide synthase in endotoxin-induced shock in mice [ J ]. Biochem Biophys Res Commun, 1995,215:114 - 121.
  • 7Carney JM, Floyd RA. Protection against oxidative damage to CNS by alpha-phenyl-tert-butyl nitrone (PBN) and other spin-trapping agents: a novel series of nonlipid free radical scavengers [ J ]. J Mol Neurosci, 1991 , 3 : 47 - 57.
  • 8Floyd RA, Carney JM. Free radical damage to protein and DNA: mechanisms involved and relevant observations on brain undergoing oxidative stress [ J ]. Ann Neurol, 1992,32 :S22 - S27.
  • 9Zhang YK, Xu GZ. The survey of synthesis and application of spin-trapping [ J ]. Chem Eng, 1989,4: 41 - 45.
  • 10Ceclile R, Sylvain M, Florence B, et al. PPN-type nitrones: preparation and use of a new series of β- phosphorylated spin-trapping agents [ J ]. Chem Soc Perkin Trans, 1997,12:2513 - 2518.

二级参考文献26

  • 1程香普,马军,段芳龄,张智清,陈庆华,金中奎,郭敏,陈香宇.阳离子脂质体联合转铁蛋白对人肿瘤细胞的靶向基因转染[J].胃肠病学和肝病学杂志,2005,14(2):147-149. 被引量:4
  • 2程骥,朱家壁,杨泗兴,王长斌.支链淀粉修饰双嘧达莫脂质体的制备及其在小鼠体内的组织分布[J].药学学报,2006,41(3):277-281. 被引量:9
  • 3Bezwoda WR,Hesdorffer CS,Dansey RD.Use of mitoxantrone-based combination chemotherapy regimens as first-line treatment for advanced breast cancer[J].South Afr Med J,1987,72:465-467.
  • 4Nakajima H,Kizaki M,Kawai Y,et al.CD7 positive acute lymphoblastic leukemia successfully treated with high dose cytosine arabinoside and mitoxantrone:a case report[J].Keio J Med,1996,45:114-117.
  • 5Yau JC,Germond C,Gluck S,et al.Mitoxantrone,prednimustine,and vincristine for elderly patients with aggressive non-Hodgkin's lymphoma[J].Am J Hematology,1998,59:156-160.
  • 6Wisloff F,Gimsing P,Hedenus M,et al.Bolus therapy with mitoxantrone and vincristine in combination with high-dose prednisone (NOP-bolus) in resistant multiple myeloma.Nordic Myeloma Study Group (NMSG)[J].Euro J Haematology,1992,48:70-74.
  • 7Rentsch KM,Schwendener RA,Hanseler E.Determination of mitoxantrone in mouse whole blood and different tissues by high-performance liquid chromatography[J].J Chromatography B:Biomedical Applications,1996,679:185-192.
  • 8Nishikawa M,Takakura Y,Hashida M.Theoretical considerations involving the pharmacokinetics of plasmid DNA[J].Adv Drug Deliv Rev,2005,57:675-688.
  • 9Tang F,Hughes JA.Introduction of a disulfide bond into a cationic lipid enhances transgene expression of plasmid DNA[J] Biochem Biophys Res Commun,1998,242:141-145.
  • 10Sun X,Zhang ZR.Optimizing the novel formulation of liposome-polycation-DNA complexes (LPD) by central composite design[J].Arch Pharm Res,2004,27:797 -805.

共引文献16

同被引文献1973

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部